Despite increases in psychedelic use, hallucinogen-related hospitalizations in the U.S. have stayed low and stable compared with substances like alcohol and opioids, according to a large healthcare claims databases covering 2016–2023.

Psilocybin therapy showed promise in reducing binge eating episodes and promoting mindful eating in a new study, with participants also reporting improvements in anxiety, depression, and overall quality of life.

Alabama’s stricter hemp regulations (HB 445) took effect January 1, 2026. Licensed retailers can sell consumable hemp to 21+ adults with strict THC limits (10 mg per serving/40 mg per package), testing and labeling requirements, and penalties for non-compliance.

Reading up on substance reactions for a safer 2026! 📚🧪 Explore test kits and harm reduction info at https://t.co/yz0QMcdt5l or the Transparency Harm Reduction App!📲

Urology wards in England and Wales are seeing a sharp rise in ketamine-related hospitalizations, especially among young people. The number of people reporting ketamine use in the past month has increased by over 250% since 2015, with chronic use causing severe, often

What are your in’s and out’s for 2026?

Source:

✅ Explore test kits and harm reduction info at https://t.co/yz0QMccVfN or the Transparency Harm Reduction App!📲

While the findings are preliminary due to the study’s small size and lack of a control group, they add to growing evidence that psychedelic-assisted therapy may offer new options for eating disorders that are often difficult to treat, warranting further research.

Improvements were also observed in depression and anxiety, with participants reporting greater mindfulness, improved emotional regulation, and healthier relationships with food following psilocybin sessions.

The treatment was well tolerated, with no serious adverse events reported, and participants showed sustained reductions in binge eating frequency for up to 14 weeks.

A recent open-label pilot study examined the safety and feasibility of a single 25 mg dose of psilocybin paired with Acceptance and Commitment Therapy (ACT)-based psychotherapy in adults with BED.

Emerging research suggests psilocybin-assisted therapy may offer a promising new approach for treating Binge Eating Disorder (BED), a condition marked by recurring episodes of uncontrolled eating and significant psychological distress.

Today we’re breaking down how to use reagent testing to save a life! 🧪

The drug supply is evolving again. ‌ Read the full blog post here: 👉 https://t.co/loEE7TYfSu

The 1st medical cannabis dispensary in Kentucky opened in December 2025 and sold out its entire inventory in just seven days due to high patient demand. They have had to temporarily pause operations while awaiting new stock due to a limitited inital harvest under state law.

Modified psilocybin compounds like CYB003 are being developed to treat depression by relaxing rigid brain patterns and encouraging new neural connections, offering a potentially more precise and reliable mental health therapy.

With lysergamides, very small dose differences can significantly change the experience. Grey market blotter is not standardized, which increases unpredictability. You can determine potency at home with the LSD QTest Kit:

The U.S. Department of Defense is funding a $4.9 M trial of MDMA-assisted therapy combined with Prolonged Exposure to treat PTSD in active-duty troops, signaling a major shift in federal support for psychedelic research.

✅ Explore test kits and harm reduction info at https://t.co/yz0QMcdt5l or the Transparency Harm Reduction App!📲